应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALRN Aileron Therapeutics Inc
休市中 04-26 16:00:00 EDT
5.00
+0.00
0.00%
盘后
5.00
+0.00
0.00%
16:00 EDT
最高
5.19
最低
4.96
成交量
8.54万
今开
5.07
昨收
5.00
日振幅
4.50%
总市值
8,486万
流通市值
8,406万
总股本
1,697万
成交额
42.82万
换手率
0.51%
流通股本
1,681万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Aileron Therapeutics, Inc.盘中异动 快速拉升15.29%报4.90美元
自选股智能写手 · 04-18
Aileron Therapeutics, Inc.盘中异动 快速拉升15.29%报4.90美元
Aileron Therapeutics, Inc.盘中异动 早盘急速跳水5.05%报5.08美元
自选股智能写手 · 04-17
Aileron Therapeutics, Inc.盘中异动 早盘急速跳水5.05%报5.08美元
Aileron Therapeutics, Inc.盘中异动 早盘股价大跌6.84%
自选股智能写手 · 04-15
Aileron Therapeutics, Inc.盘中异动 早盘股价大跌6.84%
Aileron Therapeutics, Inc.盘中异动 快速跳水6.07%
自选股智能写手 · 03-28
Aileron Therapeutics, Inc.盘中异动 快速跳水6.07%
Aileron Therapeutics Inc 预计每股亏损 16 美分 - 财报前瞻
Reuters · 03-18
Aileron Therapeutics Inc 预计每股亏损 16 美分 - 财报前瞻
Aileron Therapeutics, Inc.盘中异动 快速拉升5.12%报5.54美元
自选股智能写手 · 03-06
Aileron Therapeutics, Inc.盘中异动 快速拉升5.12%报5.54美元
Aileron Therapeutics Inc盘中异动 急速下挫5.62%报4.53美元
自选股智能写手 · 02-12
Aileron Therapeutics Inc盘中异动 急速下挫5.62%报4.53美元
Aileron Therapeutics Inc盘中异动 早盘股价大涨6.86%
自选股智能写手 · 01-31
Aileron Therapeutics Inc盘中异动 早盘股价大涨6.86%
暂无数据
公司概况
公司名称:
Aileron Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aileron Therapeutics, Inc.于2001年8月6日根据特拉华州的法律成立为Renegade Therapeutics,Inc.,于2006年开始主营业务。2007年2月,公司修改其注册证书,将其名称改为Aileron Therapeutics ,Inc.该公司是一家临床阶段的生物制药公司,专注于开发和商业化一类新型的治疗剂,称为装订肽。该公司的首席候选产品ALRN-6924针对肿瘤抑制基因p53来治疗各种各样的癌症。目前正在多个临床试验中测试的ALRN-6924通过靶向两种初级p53抑制蛋白MDMX和MDM2来重新激活p53介导的肿瘤抑制。该公司正在进行的ALRN-6924临床试验包括用于治疗晚期实体瘤或淋巴瘤的第1期试验,用于治疗外周T细胞淋巴瘤的2a期试验,或PTCL治疗急性期的1期试验骨髓性白血病或AML和晚期骨髓增生异常综合征或MDS,作为单一疗法和用于治疗与胞嘧啶阿拉伯糖苷或Ara-C组合的AML / MDS的1b期试验。
发行价格:
--
{"stockData":{"symbol":"ALRN","market":"US","secType":"STK","nameCN":"Aileron Therapeutics Inc","latestPrice":5,"timestamp":1714161600000,"preClose":5,"halted":0,"volume":85369,"hourTrading":{"tag":"盘后","latestPrice":5,"preClose":5,"latestTime":"16:00 EDT","volume":47,"amount":235,"timestamp":1714161602356},"delay":0,"floatShares":16812301,"shares":16972512,"eps":-3.420955,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"04-26 16:00:00 EDT","open":5.07,"high":5.185,"low":4.96,"amount":428152.554288,"amplitude":0.045,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.420955,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":1498708800000,"adjPreClose":5,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":5,"preClose":5,"latestTime":"16:00 EDT","volume":47,"amount":235,"timestamp":1714161602356},"volumeRatio":0.956635454104432},"requestUrl":"/m/hq/s/ALRN/tweets","defaultTab":"tweets","newsList":[{"id":"2428594246","title":"Aileron Therapeutics, Inc.盘中异动 快速拉升15.29%报4.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428594246","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428594246?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:32","pubTimestamp":1713447135,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时32分,Aileron Therapeutics, Inc.股票出现异动,股价快速拉升15.29%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。该信息摘要如下:Ladenburg Thalmann:维持Aileron Therapeutics评级,由买入调整至买入评级, 目标价由9.00美元调整至19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182132158b363a0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182132158b363a0c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428129345","title":"Aileron Therapeutics, Inc.盘中异动 早盘急速跳水5.05%报5.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428129345","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428129345?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:31","pubTimestamp":1713360676,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时31分,Aileron Therapeutics, Inc.股票出现波动,股价急速下挫5.05%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Vanda Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Novabay Pharmaceuticals, Inc.涨幅较大,Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃,换手率分别为25.24%、21.96%、16.50%,振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Viracta Therapeutics, Inc.、Rani Therapeutics Holdings, Inc.,振幅分别为16.09%、15.75%、11.06%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172131168b2ffbfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172131168b2ffbfc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427006720","title":"Aileron Therapeutics, Inc.盘中异动 早盘股价大跌6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427006720","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427006720?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:45","pubTimestamp":1713188757,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时45分,Aileron Therapeutics, Inc.股票出现波动,股价急速跳水6.84%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.20%。其相关个股中,安皮奥制药、Soligenix, Inc.、Longeveron Inc.涨幅较大,Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃,换手率分别为678.27%、614.20%、601.86%,振幅较大的相关个股有Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Longeveron Inc.,振幅分别为79.05%、73.68%、65.68%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041521455787e80739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041521455787e80739&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422862194","title":"Aileron Therapeutics, Inc.盘中异动 快速跳水6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422862194","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422862194?lang=zh_cn&edition=full","pubTime":"2024-03-28 21:36","pubTimestamp":1711632964,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日21时36分,Aileron Therapeutics, Inc.股票出现异动,股价快速下跌6.07%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,Avalo Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Nutriband Inc C/Wts 涨幅较大,Avalo Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Ibio, Inc.较为活跃,换手率分别为454.26%、364.62%、357.18%,振幅较大的相关个股有Avalo Therapeutics, Inc.、Nutriband Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为71.16%、41.04%、31.00%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328213605791d9d56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328213605791d9d56&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420247647","title":"Aileron Therapeutics Inc 预计每股亏损 16 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2420247647","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420247647?lang=zh_cn&edition=full","pubTime":"2024-03-18 20:59","pubTimestamp":1710766749,"startTime":"0","endTime":"0","summary":" * Aileron Therapeutics Inc 预计将于3月20日公布截至2023年12月31日的业绩(估计)。* * LSEG分析师对Aileron Therapeutics Inc的平均预期是每股亏损16美分。* 分析师对该公司股票的评级为 \"持有\"。* 生物技术与医学研究同行的平均一致建议也是 \"持有\"。* 华尔街对 Aileron Therapeutics Inc 的 12 个月目标价中位数为 9.00 美元,高于其上次收盘价 5.58 美元。3月18日 - 本摘要于北京时间 3 月 18 日 12:59 机器生成。除非另有说明,所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417771449","title":"Aileron Therapeutics, Inc.盘中异动 快速拉升5.12%报5.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417771449","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417771449?lang=zh_cn&edition=full","pubTime":"2024-03-06 00:49","pubTimestamp":1709657370,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日00时49分,Aileron Therapeutics, Inc.股票出现波动,股价大幅拉升5.12%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.28%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Apogee Therapeutics, Inc.、Ocean Biomedical, Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Ocean Biomedical, Inc.较为活跃,换手率分别为291.81%、191.03%、112.86%,振幅较大的相关个股有Ys Biopharma Co Ltd C/Wts 15/03/2028 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为70.24%、68.86%、67.57%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403060049307a49bf62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403060049307a49bf62&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410840270","title":"Aileron Therapeutics Inc盘中异动 急速下挫5.62%报4.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410840270","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410840270?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:30","pubTimestamp":1707748245,"startTime":"0","endTime":"0","summary":"北京时间2024年02月12日22时30分,Aileron Therapeutics Inc股票出现波动,股价大幅跳水5.62%。截至发稿,该股报4.53美元/股,成交量1.2834万股,换手率0.26%,振幅0.00%。Aileron Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.00%。Aileron Therapeutics Inc公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402122230457a434b8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402122230457a434b8c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407413556","title":"Aileron Therapeutics Inc盘中异动 早盘股价大涨6.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407413556","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407413556?lang=zh_cn&edition=full","pubTime":"2024-01-31 22:30","pubTimestamp":1706711446,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日22时30分,Aileron Therapeutics Inc股票出现异动,股价急速上涨6.86%。Aileron Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Ensysce Biosciences Inc、Neximmune Inc、Revelation Biosciences Inc涨幅较大,Revelation Biosciences Inc、Ensysce Biosciences Inc、Neximmune Inc较为活跃,换手率分别为286.52%、270.26%、100.57%,振幅较大的相关个股有Onconetix Inc、Virax Biolabs Group Limited、珐博进,振幅分别为7.77%、6.99%、6.62%。Aileron Therapeutics Inc公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401312230467a402050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401312230467a402050&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aileronrx.com","stockEarnings":[{"period":"1week","weight":0.0549},{"period":"1month","weight":-0.2786},{"period":"3month","weight":-0.0079},{"period":"6month","weight":3.2373},{"period":"1year","weight":2.5211},{"period":"ytd","weight":0.6401}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aileron Therapeutics, Inc.于2001年8月6日根据特拉华州的法律成立为Renegade Therapeutics,Inc.,于2006年开始主营业务。2007年2月,公司修改其注册证书,将其名称改为Aileron Therapeutics ,Inc.该公司是一家临床阶段的生物制药公司,专注于开发和商业化一类新型的治疗剂,称为装订肽。该公司的首席候选产品ALRN-6924针对肿瘤抑制基因p53来治疗各种各样的癌症。目前正在多个临床试验中测试的ALRN-6924通过靶向两种初级p53抑制蛋白MDMX和MDM2来重新激活p53介导的肿瘤抑制。该公司正在进行的ALRN-6924临床试验包括用于治疗晚期实体瘤或淋巴瘤的第1期试验,用于治疗外周T细胞淋巴瘤的2a期试验,或PTCL治疗急性期的1期试验骨髓性白血病或AML和晚期骨髓增生异常综合征或MDS,作为单一疗法和用于治疗与胞嘧啶阿拉伯糖苷或Ara-C组合的AML / MDS的1b期试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.225592},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.048516},{"month":3,"riseRate":0.428571,"avgChangeRate":0.007},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.032679},{"month":5,"riseRate":0.666667,"avgChangeRate":0.2627},{"month":6,"riseRate":0.5,"avgChangeRate":-0.110568},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.188521},{"month":8,"riseRate":0.428571,"avgChangeRate":0.117019},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.009358},{"month":10,"riseRate":0,"avgChangeRate":-0.1582},{"month":11,"riseRate":0.285714,"avgChangeRate":0.015436},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.045686}],"exchange":"NASDAQ","name":"Aileron Therapeutics Inc","nameEN":"Aileron Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aileron Therapeutics Inc(ALRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aileron Therapeutics Inc(ALRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aileron Therapeutics Inc,ALRN,Aileron Therapeutics Inc股票,Aileron Therapeutics Inc股票老虎,Aileron Therapeutics Inc股票老虎国际,Aileron Therapeutics Inc行情,Aileron Therapeutics Inc股票行情,Aileron Therapeutics Inc股价,Aileron Therapeutics Inc股市,Aileron Therapeutics Inc股票价格,Aileron Therapeutics Inc股票交易,Aileron Therapeutics Inc股票购买,Aileron Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aileron Therapeutics Inc(ALRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aileron Therapeutics Inc(ALRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}